Other Cancers

The Role of ctDNA/MRD Testing in Cancer: Promise, Practice, and Pitfalls

Circulating tumor DNA (ctDNA) and minimal residual disease (MRD) testing are rapidly transforming the landscape of cancer care. By offering a noninvasive window into the molecular status of a patient’s disease, these technologies are enabling earlier detection of recurrence, more precise monitoring of treatment response, and increasingly personalized therapeutic strategies.

The Role of ctDNA/MRD Testing in Cancer: Promise, Practice, and Pitfalls Read More »

Bevacizumab: The Angiogenesis Inhibitor Redefining Cancer Care

Bevacizumab (Avastin) has transformed cancer treatment since its approval in 2004, offering new hope to patients with advanced cancers. This targeted therapy works by inhibiting vascular endothelial growth factor-A (VEGF-A), a key protein that fuels tumor growth by promoting new blood vessel formation. By blocking VEGF-A, bevacizumab cuts off a tumor’s blood supply, slowing its

Bevacizumab: The Angiogenesis Inhibitor Redefining Cancer Care Read More »

Therapeutic Cancer Vaccines: Realistic Hope and Progress for Patients

Imagine you’re cheering on your immune system, giving it the best “training camp” so it can fight cancer cells as fiercely as possible. That’s basically what therapeutic cancer vaccines do. Instead of preventing disease, like a flu shot, these vaccines are designed to tackle a cancer you already have. They “teach” your immune cells to

Therapeutic Cancer Vaccines: Realistic Hope and Progress for Patients Read More »